Literature DB >> 26945088

Genetic and Epigenetic Regulation of PD-1 Expression.

Alexander P R Bally1, James W Austin1, Jeremy M Boss2.   

Abstract

The inhibitory immune receptor programmed cell death-1 (PD-1) is intricately regulated. In T cells, PD-1 is expressed in response to most immune challenges, but it is rapidly downregulated in acute settings, allowing for normal immune responses. On chronically stimulated Ag-specific T cells, PD-1 expression remains high, leading to an impaired response to stimuli. Ab blockade of PD-1 interactions during chronic Ag settings partially restores immune function and is now used clinically to treat a variety of devastating cancers. Understanding the regulation of PD-1 expression may be useful for developing novel immune-based therapies. In this review, the molecular mechanisms that drive dynamic PD-1 expression during acute and chronic antigenic stimuli are discussed. An array of cis-DNA elements, transcription factors, and epigenetic components, including DNA methylation and histone modifications, control PD-1 expression. The interplay between these regulators fine-tunes PD-1 expression in different inflammatory environments and across numerous cell types to modulate immune responses.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26945088      PMCID: PMC4780223          DOI: 10.4049/jimmunol.1502643

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  99 in total

1.  NFATc1 regulates PD-1 expression upon T cell activation.

Authors:  Kenneth J Oestreich; Hyesuk Yoon; Rafi Ahmed; Jeremy M Boss
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 2.  Transcription factors of the NFAT family: regulation and function.

Authors:  A Rao; C Luo; P G Hogan
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

3.  Activation-induced expression of human programmed death-1 gene in T-lymphocytes.

Authors:  R Vibhakar; G Juan; F Traganos; Z Darzynkiewicz; L R Finger
Journal:  Exp Cell Res       Date:  1997-04-10       Impact factor: 3.905

4.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

5.  Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.

Authors:  H Nishimura; M Nose; H Hiai; N Minato; T Honjo
Journal:  Immunity       Date:  1999-08       Impact factor: 31.745

6.  A PD-1 polymorphism is associated with disease progression in multiple sclerosis.

Authors:  Antje Kroner; Matthias Mehling; Bernhard Hemmer; Peter Rieckmann; Klaus V Toyka; Mathias Mäurer; Heinz Wiendl
Journal:  Ann Neurol       Date:  2005-07       Impact factor: 10.422

7.  Interferon-sensitive response element (ISRE) is mainly responsible for IFN-alpha-induced upregulation of programmed death-1 (PD-1) in macrophages.

Authors:  Hae-Yun Cho; Soo-Woon Lee; Su-Kil Seo; Il-Whan Choi; Inhak Choi; Soo-Woong Lee
Journal:  Biochim Biophys Acta       Date:  2008-08-15

8.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

9.  Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.

Authors:  A Gallimore; A Glithero; A Godkin; A C Tissot; A Plückthun; T Elliott; H Hengartner; R Zinkernagel
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

10.  Selective expression of an interleukin-12 receptor component by human T helper 1 cells.

Authors:  L Rogge; L Barberis-Maino; M Biffi; N Passini; D H Presky; U Gubler; F Sinigaglia
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

View more
  70 in total

Review 1.  PD-1 immunobiology in systemic lupus erythematosus.

Authors:  Colleen S Curran; Sarthak Gupta; Ignacio Sanz; Elad Sharon
Journal:  J Autoimmun       Date:  2018-11-03       Impact factor: 7.094

2.  SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells.

Authors:  Tom L Stephen; Kyle K Payne; Ricardo A Chaurio; Michael J Allegrezza; Hengrui Zhu; Jairo Perez-Sanz; Alfredo Perales-Puchalt; Jenny M Nguyen; Ana E Vara-Ailor; Evgeniy B Eruslanov; Mark E Borowsky; Rugang Zhang; Terri M Laufer; Jose R Conejo-Garcia
Journal:  Immunity       Date:  2017-01-17       Impact factor: 31.745

3.  Conserved Region C Functions To Regulate PD-1 Expression and Subsequent CD8 T Cell Memory.

Authors:  Alexander P R Bally; Yan Tang; Joshua T Lee; Benjamin G Barwick; Ryan Martinez; Brian D Evavold; Jeremy M Boss
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

4.  PD-L1- and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease.

Authors:  Ryan Galea; Hendrik J Nel; Meghna Talekar; Xiao Liu; Joshua D Ooi; Megan Huynh; Sara Hadjigol; Kate J Robson; Yi Tian Ting; Suzanne Cole; Karyn Cochlin; Shannon Hitchcock; Bijun Zeng; Suman Yekollu; Martine Boks; Natalie Goh; Helen Roberts; Jamie Rossjohn; Hugh H Reid; Ben J Boyd; Ravi Malaviya; David J Shealy; Daniel G Baker; Loui Madakamutil; A Richard Kitching; Brendan J O'Sullivan; Ranjeny Thomas
Journal:  JCI Insight       Date:  2019-09-19

5.  Exhaustion-associated regulatory regions in CD8+ tumor-infiltrating T cells.

Authors:  Giuliana P Mognol; Roberto Spreafico; Victor Wong; James P Scott-Browne; Susan Togher; Alexander Hoffmann; Patrick G Hogan; Anjana Rao; Sara Trifari
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-10       Impact factor: 11.205

6.  Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment.

Authors:  Xingzhe Ma; Enguang Bi; Yong Lu; Pan Su; Chunjian Huang; Lintao Liu; Qiang Wang; Maojie Yang; Matthew F Kalady; Jianfei Qian; Aijun Zhang; Anisha A Gupte; Dale J Hamilton; Chengyun Zheng; Qing Yi
Journal:  Cell Metab       Date:  2019-04-25       Impact factor: 27.287

7.  Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4+ T Cell Dysfunction.

Authors:  Jie Wu; Hedong Zhang; Xiaomin Shi; Xiang Xiao; Yihui Fan; Laurie J Minze; Jin Wang; Rafik M Ghobrial; Jiahong Xia; Roger Sciammas; Xian C Li; Wenhao Chen
Journal:  Immunity       Date:  2017-12-05       Impact factor: 31.745

8.  In Vitro Assessment of Putative PD-1/PD-L1 Inhibitors: Suggestions of an Alternative Mode of Action.

Authors:  Derek J Blevins; Ronan Hanley; Trevor Bolduc; David A Powell; Michael Gignac; Kayleigh Walker; Mark D Carr; Fraser Hof; Jeremy E Wulff
Journal:  ACS Med Chem Lett       Date:  2019-07-02       Impact factor: 4.345

9.  PD-1 Expression during Acute Infection Is Repressed through an LSD1-Blimp-1 Axis.

Authors:  Alexander P R Bally; Dennis K Neeld; Peiyuan Lu; Parimal Majumder; Yan Tang; Benjamin G Barwick; Qing Wang; Jeremy M Boss
Journal:  J Immunol       Date:  2019-12-06       Impact factor: 5.422

10.  CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia.

Authors:  Hadas Lewinsky; Avital F Barak; Victoria Huber; Matthias P Kramer; Lihi Radomir; Lital Sever; Irit Orr; Vita Mirkin; Nili Dezorella; Mika Shapiro; Yosef Cohen; Lev Shvidel; Martina Seiffert; Yair Herishanu; Shirly Becker-Herman; Idit Shachar
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.